Cell MedX Corp. Closes Private Placement Financing
Yahoo FinanceMar 19 13:28 ET
Cell MedX Corp. Announces Resignation of Director
Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commer
newsfileFeb 28 16:47 ET
Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commer
newsfileFeb 26 09:15 ET
Over $6M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
BenzingaJan 11 08:39 ET
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
Vancouver, British Columbia--(Newsfile Corp. - December 19, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commer
newsfileDec 19, 2023 14:24 ET
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securitie
newsfileNov 27, 2023 13:16 ET
Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - November 9, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commerc
newsfileNov 9, 2023 08:00 ET
Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO
Carson City, Nevada--(Newsfile Corp. - June 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of
newsfileJun 27, 2022 08:05 ET
Cell MedX names new CEO
Cell MedX (OTCQB:CMXC) named Dwayne Yaretz as its new CEO, to succeed McEnulty, on Wednesday.The biotech company told Yaretz has held leadership roles in private and public companies."I am excited to
Seeking AlphaApr 27, 2022 09:13 ET
Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director
Carson City, Nevada--(Newsfile Corp. - April 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of
newsfileApr 27, 2022 09:06 ET
No Data
No Data